» Articles » PMID: 29295550

Lessons Learned from Protective Immune Responses to Optimize Vaccines Against Cryptosporidiosis

Overview
Journal Pathogens
Date 2018 Jan 4
PMID 29295550
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In developing countries, cryptosporidiosis causes moderate-to-severe diarrhea and kills thousands of infants and toddlers annually. Drinking and recreational water contaminated with spp. oocysts has led to waterborne outbreaks in developed countries. A competent immune system is necessary to clear this parasitic infection. A better understanding of the immune responses required to prevent or limit infection by this protozoan parasite is the cornerstone of development of an effective vaccine. In this light, lessons learned from previously developed vaccines against spp. are at the foundation for development of better next-generation vaccines. In this review, we summarize the immune responses elicited by naturally and experimentally-induced spp. infection and by several experimental vaccines in various animal models. Our aim is to increase awareness about the immune responses that underlie protection against cryptosporidiosis and to encourage promotion of these immune responses as a key strategy for vaccine development. Innate and mucosal immunity will be addressed as well as adaptive immunity, with an emphasis on the balance between T1/T2 immune responses. Development of more effective vaccines against cryptosporidiosis is needed to prevent spp.-related deaths in infants and toddlers in developing countries.

Citing Articles

P23-Specific IgY Significantly Reduces Diarrhea and Oocyst Shedding in Calves Experimentally Infected with .

Mira A, Garro C, de Alba P, Monti D, Lang M, Vivas A Vaccines (Basel). 2025; 13(2).

PMID: 40006709 PMC: 11860195. DOI: 10.3390/vaccines13020162.


Gut Barrier Dysfunction and Microbiota Variations in Cryptosporidiosis: A Comprehensive Review.

Ali M, Xu C, Wang M, Hina Q, Ji Y, Anwar S Vet Sci. 2025; 12(2).

PMID: 40005845 PMC: 11861801. DOI: 10.3390/vetsci12020085.


Cryptosporidiosis outbreaks linked to the public water supply in a military camp, France.

Watier-Grillot S, Costa D, Petit C, Razakandrainibe R, Larreche S, Tong C PLoS Negl Trop Dis. 2022; 16(9):e0010776.

PMID: 36095017 PMC: 9499286. DOI: 10.1371/journal.pntd.0010776.


Controlled Human Infection Models To Accelerate Vaccine Development.

Choy R, Louis Bourgeois A, Ockenhouse C, Walker R, Sheets R, Flores J Clin Microbiol Rev. 2022; 35(3):e0000821.

PMID: 35862754 PMC: 9491212. DOI: 10.1128/cmr.00008-21.


Dual Transcriptomics To Determine Gamma Interferon-Independent Host Response to Intestinal Cryptosporidium parvum Infection.

Gallego-Lopez G, Mendoza Cavazos C, Tibabuzo Perdomo A, Garfoot A, OConnor R, Knoll L Infect Immun. 2021; 90(2):e0063821.

PMID: 34928716 PMC: 8852703. DOI: 10.1128/iai.00638-21.


References
1.
Neurath M, Finotto S, Glimcher L . The role of Th1/Th2 polarization in mucosal immunity. Nat Med. 2002; 8(6):567-73. DOI: 10.1038/nm0602-567. View

2.
Lodoen M, Lanier L . Natural killer cells as an initial defense against pathogens. Curr Opin Immunol. 2006; 18(4):391-8. PMC: 7127478. DOI: 10.1016/j.coi.2006.05.002. View

3.
Marchi L, Sesti-Costa R, Ignacchiti M, Chedraoui-Silva S, Mantovani B . In vitro activation of mouse neutrophils by recombinant human interferon-gamma: increased phagocytosis and release of reactive oxygen species and pro-inflammatory cytokines. Int Immunopharmacol. 2013; 18(2):228-35. DOI: 10.1016/j.intimp.2013.12.010. View

4.
Wyatt C, Perryman L . Detection of mucosally delivered antibody to Cryptosporidium parvum p23 in infected calves. Ann N Y Acad Sci. 2001; 916:378-87. DOI: 10.1111/j.1749-6632.2000.tb05316.x. View

5.
Korpe P, Haque R, Gilchrist C, Valencia C, Niu F, Lu M . Natural History of Cryptosporidiosis in a Longitudinal Study of Slum-Dwelling Bangladeshi Children: Association with Severe Malnutrition. PLoS Negl Trop Dis. 2016; 10(5):e0004564. PMC: 4856361. DOI: 10.1371/journal.pntd.0004564. View